Jingwu Zhang Zang

Director/Board Member presso HH&L ACQUISITION CO.

Patrimonio netto: 8 M $ in data 31/03/2024

68 anni

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Jingwu Zhang Zang

Società	Posizione	Inizio	Fine
HH&L ACQUISITION CO.	Director/Board Member	04/02/2021	-
HH&L ACQUISITION CO.	Independent Dir/Board Member	04/02/2021	-
I-MAB Biopharma Co., Ltd. I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China.	Founder	01/06/2016	-
	Chairman	24/08/2016	-
	Chief Executive Officer	24/08/2016	-

Società	Posizione	Inizio	Fine
I-MAB	Director/Board Member	01/10/2019	01/03/2021
	Chief Executive Officer	01/01/2022	30/09/2022
	Chairman	01/03/2021	10/02/2024
	Founder	30/06/2016	10/02/2024
SIMCERE PHARMACEUTICAL GROUP LIMITED	President	01/09/2013	01/04/2016
BioSciKin Co., Ltd. BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China.	Chief Tech/Sci/R&D Officer	01/09/2013	01/04/2016
	President	01/09/2013	01/04/2016
Glaxosmithkline China Ltd.	Chief Tech/Sci/R&D Officer	01/04/2007	01/06/2013
Shanghai Jiao Tong University School of Medicine	Corporate Officer/Principal	01/06/2002	01/04/2007
Institut Pasteur de Shanghai Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China.	Director/Board Member	01/10/2004	01/09/2006
The Institute of Health Sciences	Director/Board Member	-	-
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-	-
░░░░░░ ░░░░░░░ ░░ ░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-	-

Shanghai Jiao Tong University	Doctorate Degree
Vrije Universiteit Brussel	Doctorate Degree

Distribuzione geografica

Posizioni

Director/Board Member	4
Corporate Officer/Principal	3
President	2

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
SIMCERE PHARMACEUTICAL GROUP LIMITED	Health Technology
I-MAB	Health Technology

Aziende private	7
Opexa Pharmaceuticals, Inc.	Health Technology
Institut Pasteur de Shanghai Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China.	Commercial Services
Glaxosmithkline China Ltd.
The Institute of Health Sciences
BioSciKin Co., Ltd. BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China.	Health Technology
I-MAB Biopharma Co., Ltd. I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China.	Health Technology
HH&L Acquisition Co. HH&L Acquisition Co. Financial ConglomeratesFinance HH&L Acquisition Co. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on September 4, 2020 and is headquartered in Hong Kong.	Finance